Advertisement

Topics

In Phase III trial, brexanolone does not benefit epilepsy patients

07:47 EDT 13 Sep 2017 | thePharmaLetter

The Phase III STATUS trial of brexanolone has failed to meet its primary endpoint, Massachusetts-based…

Original Article: In Phase III trial, brexanolone does not benefit epilepsy patients

NEXT ARTICLE

More From BioPortfolio on "In Phase III trial, brexanolone does not benefit epilepsy patients"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...